Resources

Client Alerts, News Articles, Blog Posts, & Multimedia

Everything you need to know about BMD and the industry.

Navigating the New Era of Immigration Enforcement

Client Alert

What Employers Need to Know in 2025

Introduction

The landscape of U.S. business immigration is undergoing a seismic shift in 2025. For multinational corporations, the stakes have never been higher: federal agencies are intensifying scrutiny, increasing site visits, and rolling out new compliance requirements. These changes are not just bureaucratic hurdles—they directly impact your ability to hire and retain global talent, maintain legal compliance, and avoid costly disruptions.

This post will break down the latest enforcement trends, explain what they mean for your business, and provide actionable strategies to stay ahead.

1. The Rise of Immigration Audits and Site Visits

What’s Changing? Federal agencies, including U.S. Citizenship and Immigration Services (USCIS) and Immigration and Customs Enforcement (ICE), are conducting more frequent and detailed audits. Site visits—once relatively rare—are now a routine part of the compliance landscape. These inspections target everything from H-1B and L-1 visa holders to PERM labor certifications and I-9 records.

Why It Matters for Multinational Employers

  • Increased Scrutiny: Audits are no longer limited to high-risk industries or random checks. Employers in all sectors, especially those with large foreign workforces, should expect unannounced visits.
  • Broader Scope: Inspectors are reviewing not just visa documentation, but also payroll records, job descriptions, and even workplace conditions to ensure compliance with labor laws.
  • Higher Stakes: Non-compliance can result in fines, visa revocations, or even criminal charges for willful violations.

Real-World Impact A recent report from the Bush Center highlights that immigration arrests have more than doubled in 38 states, with ICE conducting an average of 666 arrests per day nationwide—up from fewer than 300 daily in 2024. While these numbers include all immigration enforcement, they underscore the heightened environment for all employers.

Read the complete article to find out more about these policies, strategies, and consequences for employees at www.removal-defense.com. Get a deeper understanding of:

2. The Role of the New Office of Immigration Policy

3. Actionable Strategies for Multinational Corporations

4. The Cost of Non-Compliance: Penalties and Consequences for Employers

5. The Road Ahead: Staying Proactive in a Shifting Landscape

For guidance on these immigration issues, please contact BMD Member Robert Ratliff at raratliff@bmdllc.com. With over 25 years of trial experience in criminal defense and immigration law, Robert’s unique insights as a former Immigration Judge allow him to offer strategic guidance for clients facing complex immigration challenges.


Effective December 12, 2024: Key Updates to Ohio Medicaid Rules for CPC and CMC Programs

Ohio Medicaid has amended rules for the Comprehensive Primary Care (CPC) and Comprehensive Maternal Care (CMC) programs, effective December 12, 2024. Key updates include expanded provider eligibility, stricter cultural competency training timelines, new clinical quality metrics, and changes to maternal care requirements.

Ohio Medicaid Extends Timely Filing Deadline Until 2025

The Ohio Department of Medicaid (ODM) recently announced that it is extending its timely filing deadline to February 28, 2025. According to ODM, roughly 2% of providers have contract issues preventing them from meeting the previous timely filing deadline of December 1, 2024.

Another Drug Manufacturer Pursues Rebate Program as 340B Alternative

Some of the nation’s largest drug manufacturers are forging ahead to implement rebate programs for 340B drugs, even after the federal government has called these programs illegal. While it is unclear how these federal courts will rule, this could threaten the sustainability of safety net providers and their patients.

Hurry Up, STOP. . .Has CTA Been Struck Down By Courts?

Following a recent case in Texas, uncertainty has arisen regarding whether clients should file "beneficial owners" reports. This is a result of the Federal Government enjoined from enforcing the CTA. Contact your BMD Member Blake Gerney to find out how this affects you.

DEA and HHS Issue its Third Extension of Telemedicine Flexibilities through 2025

The DEA and U.S. Department of Health and Human Services (HHS) have extended telemedicine flexibilities for prescribing controlled medications through December 31, 2025. This extension builds on temporary exceptions made in 2020 due to COVID-19, allowing providers to prescribe Schedule II-V controlled substances based on a telemedicine evaluation alone. The extension ensures continued patient access to necessary prescriptions and provides time for providers to comply with future regulations.